BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34868557)

  • 1. Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden.
    Ren A; Prassas I; Sugumar V; Soosaipillai A; Bernardini M; Diamandis EP; Kulasingam V
    F1000Res; 2021; 10():509. PubMed ID: 34868557
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden.
    Ren AH; Prassas I; Soosaipillai A; Jarvi S; Gallinger S; Kulasingam V; Diamandis EP
    F1000Res; 2020; 9():732. PubMed ID: 33274048
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and validation of differential plasma proteins levels in epithelial ovarian cancer.
    Periyasamy A; Gopisetty G; Subramanium MJ; Velusamy S; Rajkumar T
    J Proteomics; 2020 Aug; 226():103893. PubMed ID: 32634479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
    Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.
    Timms JF; Arslan-Low E; Kabir M; Worthington J; Camuzeaux S; Sinclair J; Szaub J; Afrough B; Podust VN; Fourkala EO; Cubizolles M; Kronenberg F; Fung ET; Gentry-Maharaj A; Menon U; Jacobs I
    Proteomics Clin Appl; 2014 Dec; 8(11-12):982-93. PubMed ID: 25290619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection.
    Skubitz APN; Boylan KLM; Geschwind K; Cao Q; Starr TK; Geller MA; Celestino J; Bast RC; Lu KH; Koopmeiners JS
    Cancer Prev Res (Phila); 2019 Mar; 12(3):171-184. PubMed ID: 30709840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study.
    Liao CC; Mehta A; Ward NJ; Marsh S; Arulampalam T; Norton JD
    World J Surg Oncol; 2010 Apr; 8():33. PubMed ID: 20420661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury-A Pilot Study.
    Chen M; Ren AH; Prassas I; Soosaipillai A; Lim B; Fraser DD; Diamandis EP
    J Appl Lab Med; 2021 Sep; 6(5):1165-1178. PubMed ID: 33778875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer.
    Qiu C; Duan Y; Wang B; Shi J; Wang P; Ye H; Dai L; Zhang J; Wang X
    Front Immunol; 2021; 12():698312. PubMed ID: 34489945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment.
    Finkernagel F; Reinartz S; Schuldner M; Malz A; Jansen JM; Wagner U; Worzfeld T; Graumann J; von Strandmann EP; Müller R
    Theranostics; 2019; 9(22):6601-6617. PubMed ID: 31588238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study.
    Watcharatanyatip K; Chutipongtanate S; Chokchaichamnankit D; Weeraphan C; Mingkwan K; Luevisadpibul V; Newburg DS; Morrow AL; Svasti J; Srisomsap C
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.
    McGuckin MA; Layton GT; Bailey MJ; Hurst T; Khoo SK; Ward BG
    Gynecol Oncol; 1990 May; 37(2):165-71. PubMed ID: 1693126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer.
    Shen Q; Polom K; Williams C; de Oliveira FMS; Guergova-Kuras M; Lisacek F; Karlsson NG; Roviello F; Kamali-Moghaddam M
    EBioMedicine; 2019 Jun; 44():322-333. PubMed ID: 31151932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
    Fredriksson S; Horecka J; Brustugun OT; Schlingemann J; Koong AC; Tibshirani R; Davis RW
    Clin Chem; 2008 Mar; 54(3):582-9. PubMed ID: 18171715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiplex platform for the identification of ovarian cancer biomarkers.
    Boylan KLM; Geschwind K; Koopmeiners JS; Geller MA; Starr TK; Skubitz APN
    Clin Proteomics; 2017; 14():34. PubMed ID: 29051715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.
    Ye B; Cramer DW; Skates SJ; Gygi SP; Pratomo V; Fu L; Horick NK; Licklider LJ; Schorge JO; Berkowitz RS; Mok SC
    Clin Cancer Res; 2003 Aug; 9(8):2904-11. PubMed ID: 12912935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
    Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
    J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.
    Tang HY; Beer LA; Tanyi JL; Zhang R; Liu Q; Speicher DW
    J Proteomics; 2013 Aug; 89():165-78. PubMed ID: 23792823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.
    Ostendorff HP; Awad A; Braunschweiger KI; Liu Z; Wan Z; Rothschild KJ; Lim MJ
    J Immunol Methods; 2013 Dec; 400-401():58-69. PubMed ID: 24161315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
    Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
    BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.